Table 1

Description of the 49 studies selected for analysis

Type of study/ populationOADiabetes mellitusGeneral population
AuthorYearSample sizeAuthorYearSample sizeAuthorYearSample size
Cross-sectionalStürmer et al162001809Ray et al192011100Inoue et al202011795
Lanas et al2120103293Sarkar et al22200880Puenpatom and Victor720097714
Reeuwijk et al232010288Miksch et al2420091399Dahaghin et al2520073585
Adams et al26201339 031Martin et al271997739
Shirinsky and Shirinsky*2820135674Hart et al291995979
Cimmino et al3020052393Typpo311985518
Magnusson et al322014530Schett et al102009927
 Conaghan et al3320141187Navarro et al*342012438
Zullig et al352014300Orellana et al*362012324
Bija et al372014148Anderson and Felson3819885193
Silveri et al39199448
Perruccio et al*402013983
Yoshimura et al820111690
Wang et al4120131877
Shin4220142363
CohortJamsen et al43201296 754Davies-Tuck et al442012179
Baker et al*45201362Siviero et al4620091867
Peniston et al472012947Engstrom et al4820095194
Frey et al1719961514
Bagge et al491991340
(Schett†10)2012
Haugen et al5020131348
Sowers et al512009664
Visser et al52 5320134980
Case-control§Philbin et al54199669Ladjimi et al55198568
Denko et al561994135Nieves-Plaza et al572013226
Cimmino et al5819901226
Lindberg and Nilsson591985558
Dequeker et al60198253
Rahman et al612013150 267
Wang et al62*2013856 168
Horn et al63199276
  • *Data from congress.

  • †One analysis with a cohort study (not analysed), one analysis with a cross-sectional study, with the same population (included in analysis).

  • ‡One analysis with radiographic OA, one analysis with symptomatic OA.

  • §Size for total number of patients (cases+controls).

  • EULAR, The European League Against Rheumatism; OA, osteoarthritis.